AnaBios aims to establish the safety and efficacy of novel compounds through its advanced, human-focused translational technologies, including superior quality human tissue samples and functional assays focused, as well as human primary cells through its subsidiary Cell Systems.


Ossiform provides scaffold-based bioceramic 3D cell culture systems that mimic the architecture and complexity of calcified bone tissue. The scaffolds are made from a nonpolymeric bioink consisting solely of β-TCP.


BiomimX develops the next generation of beating organs-on-chips. uBeat® Platforms and connected hardware provide 3D miniaturized constructs with a tunable mechanical stimulation to model human organs’ function and diseases. uBeat® products and customized drug screening services are available.


Alcyomics is a pre-clinical service provider using Skimune®, non-artificial human skin explants to predict adverse immune reactions of novel compounds. The Skimune® platform also assess the efficacy of monoclonal antibodies, immune inhibitors and safety of cellular therapies.